# Eyegaze Inc. – FDA Inspection, May 2, 2025

Source: https://www.keypedia.com/records/fda_inspections/eyegaze-inc/229a9afe-51b4-4cb5-be0d-23a8eb4b1b46
Source feed: FDA_Inspections

> FDA inspection 1268684 of Eyegaze Inc., May 02, 2025. Classification: No Action Indicated (NAI). 3 citations under 21 CFR parts 801 and 820. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1268684
- Company Name: Eyegaze Inc.
- Inspection Date: 2025-05-02
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Postmarket Assurance: Medical Devices
- Product Type: Medical Devices & Rad Health
- Center: Medical Devices & Rad Health
- Office Name: Baltimore District Office
- Citation Count: 3

## Related Documents

- FDA Inspection 1153994 - 2021-10-08
- [FDA Inspection 1068174 - 2018-10-05](https://www.keypedia.com/records/fda_inspections/eyegaze-inc/8c0630b9-f795-4444-ae79-fcba24d7df43)
- FDA Inspection 986370 - 2016-09-15
- FDA Inspection 923120 - 2015-04-23

## Related Officers

- [Investigator](https://www.keypedia.com/people/heath-a-gerber/3c47dcdd-875c-4f3c-8165-839354a53d8b)

Company: https://www.keypedia.com/companies/eyegaze-inc/b7226d9c-3955-4414-9eaa-53fe6e780b31

Office: https://www.keypedia.com/offices/baltimore-district-office/6be371ff-03e9-4039-999c-ff170f17a9fa
